Concepedia

Author

F. Lejeune

AVL (France)

Also Known As

F J Lejeune, F LEJEUNE, F Lejeune, F. J. Lejeune, F. Lejeune, Françoise Lejeune, Fran�oise Lejeune

76

Publications

2.2K

Citations

17

H-Index

40

Concepts

All Affiliations

AVL (France)Servier (France)Hôpital Laennec
FL

About

F. Lejeune is an author at AVL (France) specializing in medicine, social sciences, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

579

2

Social Sciences

5

5

550

3

Neuroscience

5

5

550

4

Engineering

1

1

18

5

Pathology

1

1

11

F. Lejeune

×

19

Publications

2.1K

Citations

17

H-Index

YearCitations

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Mark J. Millan, Alain P. Gobert, F. Lejeune,

Journal of Pharmacology and Experimental Therapeutics

2003

509

Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

Alain P. Gobert, Jean‐Michel Rivet, F. Lejeune,

Synapse

2000

335

Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

Mark J. Millan, Adrian Newman‐Tancredi, Val�rie Audinot,

Synapse

2000

191

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α<sub>2</sub>‐adrenergic and serotonin<sub>2C</sub> receptors: a comparison with citalopram

Mark J. Millan, Alain P. Gobert, Jean‐Michel Rivet,

European Journal of Neuroscience

2000

167

S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine

M J Millan, Alain P. Gobert, F. Lejeune,

Journal of Pharmacology and Experimental Therapeutics

2001

143

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535

F. Lejeune, Mark J. Millan

Synapse

1998

100

Interactions of (+)- and (−)-8- and 7-Hydroxy-2-(Di-n-Propylamino)tetralin at Human (h)D3, hD2 and h Serotonin1A Receptors and Their Modulation of the Activity of Serotoninergic and Dopaminergic Neurones in Rats

F. Lejeune, Adrian Newman‐Tancredi, Valérie Audinot,

Journal of Pharmacology and Experimental Therapeutics

1997

94

S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.

Mark J. Millan, F. Lejeune, Alain P. Gobert,

PubMed

2000

85

Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.

M J Millan, Hervé Canton, Alain P. Gobert,

Journal of Pharmacology and Experimental Therapeutics

1994

76

Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.

Alain P. Gobert, F. Lejeune, Jean‐Michel Rivet,

Journal of Pharmacology and Experimental Therapeutics

1995

68

Page 1